Latest News & Events
Procarta attends the Microbiome Invest Conference 2019
The Procarta management team, comprised of Andrew Lightfoot, Nikki D'Arcy and Martin…Read more
"No Time to Wait: Securing the future from drug-resistant infections"
Infectious Diseases Hub article on the latest report from the UN Interagency…Read more
Procarta presents our Transcription Factor Decoy technology at ECCMID 2019
Procarta Co-founder Professor Michael McArthur presented our exciting Transcription Factor Decoy (TFD)…Read more
Procarta presents at the Microbiology Society Annual Conference 2019
The Procarta research team, lead by Procarta Co-founder Professor Michael McArthur, attended…Read more
Procarta CEO attends the Berlin CMR Conference 2019
Procarta Biosystems Ltd. attended the Berlin Novel Antimicrobials and AMR Diagnostics Conference…Read more
PROCARTA ANNOUNCES €1.5 MILLION INVESTMENT FOR NEW CLASS OF ANTIBIOTICS TO COMBAT ANTIMICROBIAL RESISTANCE
Press Release - Stevenage, UK, 5th March, 2019 – Procarta Biosystems, a…Read more
"Antibiotic resistance plan to fight 'urgent' global threat"
BBC News report on British Government plans to combat antimicrobial resistance.
Procarta at BioSeed Life Science Investment Event
CEO of Procarta Biosystems Ltd. Dr. Andrew Lightfoot attended the BioSeed Early…Read more
Procarta Biosystems Ltd speak at BioInfect 2018
Procarta's Chief Scientific Officer, Professor Michael McArthur, was invited to speak at…Read more
NOW HIRING - Post-doctoral and Research Technician positions
Two positions are available to join a laboratory developing novel oligonucleotide antimicrobials,…Read more